newsfilter
← Latest News
Business Wire·

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Charles River Laboratories International, Inc. (NYSE:CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging